Musculoskeletal and prostate effects of combined testosterone and finasteride administration in older hypogonadal men: a randomized, controlled trial

Testosterone acts directly at androgen receptors and also exerts potent actions following 5α-reduction to dihydrotestosterone (DHT). Finasteride (type II 5α-reductase inhibitor) lowers DHT and is used to treat benign prostatic hyperplasia. However, it is unknown whether elevated DHT mediates either...

Descrición completa

Gardado en:
Detalles Bibliográficos
Main Authors: Borst, Stephen E., Yarrow, Joshua F., Conover, Christine F., Nseyo, Unyime, Meuleman, John R., Lipinska, Judyta A., Braith, Randy W., Beck, Darren T., Martin, Jeffrey S., Morrow, Matthew, Roessner, Shirley, Beggs, Luke A., McCoy, Sean C., Cannady, Darryl F., Shuster, Jonathan J.
Formato: Artigo
Idioma:Inglês
Publicado: American Physiological Society 2013
Assuntos:
Articles
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC4073894/
https://ncbi.nlm.nih.gov/pubmed/24326421
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1152/ajpendo.00592.2013
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares